2023
Body mass index and obesity-related behaviors in African American church-based networks: A social network analysis
Nam S, Jung S, Vlahov D, Latkin C, Kershaw T, Whittemore R. Body mass index and obesity-related behaviors in African American church-based networks: A social network analysis. PLOS ONE 2023, 18: e0281145. PMID: 36913354, PMCID: PMC10010537, DOI: 10.1371/journal.pone.0281145.Peer-Reviewed Original Research
2022
COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study
Poghosyan H, Ni Z, Vlahov D, Nelson L, Nam S. COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study. Journal Of Community Health 2022, 48: 315-324. PMID: 36427111, PMCID: PMC9702715, DOI: 10.1007/s10900-022-01174-5.Peer-Reviewed Original ResearchMeSH KeywordsAgedCOVID-19COVID-19 VaccinesCross-Sectional StudiesHumansMedicareNeoplasmsUnited StatesVaccinationConceptsCOVID-19 vaccineCOVID-19 vaccine hesitancyCancer historyVaccine hesitancyMedicare beneficiariesVaccine uptakeMultivariable logistic regression modelCOVID-19 vaccine uptakeVaccine hesitancy ratesOngoing health conditionsCOVID-19 vaccinationLogistic regression modelsComplex survey designLack of recommendationsHesitancy ratesVaccine benefitsCommon reasonHesitant individualsSide effectsUS populationVaccineHealth conditionsCross-sectional dataHesitancyRegression models
2007
Identifying injection drug users at risk of nonfatal overdose.
Coffin P, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine 2007, 14: 616-23. PMID: 17554010, DOI: 10.1197/j.aem.2007.04.005.Peer-Reviewed Original ResearchConceptsDrug usersHabitual drug usersNonfatal overdoseAggressive prevention effortsAgonist maintenance treatmentSerious withdrawal symptomsInjection drug usersFurther longitudinal studiesIndividual-level risk factorsTake-home naloxoneOverdose prevention interventionsFuture overdosesMaintenance treatmentWithdrawal symptomsRisk factorsDrug overdoseRecent overdoseEmergency physiciansOverdose riskPrevention interventionsHigh riskOverdoseMedical careYounger ageU.S. adults
2006
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users
Smit E, Crespo C, Semba R, Jaworowicz D, Vlahov D, Ricketts E, Ramirez-Marrero F, Tang A. Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 2006, 18: 1040-1045. PMID: 17012097, DOI: 10.1080/09540120600580926.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-positive participantsHIV-positive injection drug usersInjection drug useHIV-negativeVigorous activityPhysical activityDrug usersDrug usePaffenbarger Physical Activity QuestionnaireRecent injection drug usersHIV-negative injection drug usersIntravenous Experience cohortActive antiretroviral therapyCohort of HIVHIV-negative participantsPhysical Activity QuestionnairePhysical activity levelsAntiretroviral therapyHIV infectionViral loadHIV treatmentActivity QuestionnaireAnthropometric measurementsEnergy expenditureDeterminants of influenza vaccination in hard-to-reach urban populations
Bryant W, Ompad D, Sisco S, Blaney S, Glidden K, Phillips E, Vlahov D, Galea S, Group F. Determinants of influenza vaccination in hard-to-reach urban populations. Preventive Medicine 2006, 43: 60-70. PMID: 16684559, DOI: 10.1016/j.ypmed.2006.03.018.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedCross-Sectional StudiesFemaleHumansImmunization ProgramsInfluenza, HumanMaleMiddle AgedNew York CityPovertyConceptsInfluenza vaccinationRoutine medical careMedical careReceipt of healthInfluenza vaccination ratesCross-sectional studyVenue-based samplingGovernment health insuranceTime of surveyLow annual incomeVaccination ratesMultivariable modelVaccinationMinority raceHealth insuranceEast HarlemDisadvantaged urban areasReach populationsCareTotal respondentsSocial servicesParticipantsNew York CityHealthPrevious year
2005
Urban built environment and depression: a multilevel analysis
Galea S, Ahern J, Rudenstine S, Wallace Z, Vlahov D. Urban built environment and depression: a multilevel analysis. Journal Of Epidemiology & Community Health 2005, 59: 822. PMID: 16166352, PMCID: PMC1732922, DOI: 10.1136/jech.2005.033084.Peer-Reviewed Original ResearchConceptsNew York CityNew York City HousingUrban planning effortsFuture prospective workNeighborhood-level incomeCity housingVacancy SurveyNeighborhood of residencePlanning effortsNeighborhoodNYC neighborhoodsLifetime depressionYork CityPoor featuresLevel incomeManagement reportsEnvironmentPopulation mental healthResidencePoor qualityCross-sectional surveyHousingRace/ethnicityProspective workCity
2004
Mental health status among ethnic albanians seeking medical care in an emergency department two years after the war in Kosovo A pilot project
Fernandez W, Galea S, Ahern J, Sisco S, Waldman R, Koci B, Vlahov D. Mental health status among ethnic albanians seeking medical care in an emergency department two years after the war in Kosovo A pilot project. Annals Of Emergency Medicine 2004, 43: e1-e8. PMID: 14747823, DOI: 10.1016/j.annemergmed.2003.09.012.Peer-Reviewed Original ResearchConceptsMental component summary scoresComponent summary scoresMental health statusED patientsShort Form-36 mental component summary scoreSummary scoresLower mental component summary scoresHealth statusMedical careSeparate multivariable linear regression modelsShort Form-36Multivariable linear regression modelsPatients 2 yearsFourth Edition criteriaTraumatic eventsPublic health interventionsMental health problemsPosttraumatic stress disorderHarvard Trauma QuestionnairePosttraumatic stress disorder (PTSD) symptomsSpecific vulnerable populationsForm-36Emergency departmentPsychosocial burdenFemale sexExplaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.
Fuller C, Galea S, Blaney S, Ompad D, Deren S, Des Jarlais D, Vlahov D. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity & Disease 2004, 14: 589-96. PMID: 15724781.Peer-Reviewed Original Research
2003
Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort
Bernstein K, Jacobson L, Jenkins F, Vlahov D, Armenian H. Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort. Sexually Transmitted Diseases 2003, 30: 199-204. PMID: 12616135, DOI: 10.1097/00007435-200303000-00004.Peer-Reviewed Original ResearchConceptsHHV-8 seroprevalenceRisk factorsHHV-8Human herpesvirus type 8 infectionLarger body mass indexHuman herpesvirus type 8Drug user cohortHHV-8 seropositivityInjection drug useBody mass indexMultivariate logistic regressionCross-sectional studyDrug user populationGenital wartsMass indexGeneral populationDrug useSeroprevalenceIndirect immunofluorescenceLogistic regressionIDUsInfectionType 8User cohortSexual behavior
2002
Drug use frequency among street-recruited heroin and cocaine users in harlem and the bronx before and after September 11, 2001
Factor S, Wu Y, Monserrate J, Edwards V, Cuevas Y, Del Vecchio S, Vlahov D. Drug use frequency among street-recruited heroin and cocaine users in harlem and the bronx before and after September 11, 2001. Journal Of Urban Health 2002, 79: 404-408. PMID: 12200509, PMCID: PMC3456797, DOI: 10.1093/jurban/79.3.404.Peer-Reviewed Original Research
2001
Influence of Injection Drug Use Behavior on Reported Antiretroviral Therapy Use Among Women in the HIV Epidemiology Research Study: On-Site Versus Referral Care.
Rompalo A, Shah N, Mayer K, Schuman P, Klein R, Smith D, Vlahov D. Influence of Injection Drug Use Behavior on Reported Antiretroviral Therapy Use Among Women in the HIV Epidemiology Research Study: On-Site Versus Referral Care. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 28. PMID: 11579274, DOI: 10.1097/00042560-200109010-00005.Peer-Reviewed Original ResearchConceptsInjection drug useInjection drug usersAntiretroviral therapy useAntiretroviral therapyART useDrug usersDrug useHIV careTherapy useSelf-reported injection drug useMedical careCD4 cell count categorySelf-reported ART useActive injection drug usersSexual contactFemale injection drug usersInjection drug use behaviorsPneumocystis carinii prophylaxisActive antiretroviral therapyProspective cohort studyHIV Epidemiology Research StudyHealth care providersCross-sectional analysisDrug use behaviorsReferral careHighly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected Women
Semba R, Shah N, Klein R, Mayer K, Schuman P, Gardner L, Vlahov D. Highly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected Women. AIDS Patient Care And STDs 2001, 15: 473-480. PMID: 11587633, DOI: 10.1089/108729101753145466.Peer-Reviewed Original ResearchConceptsPrevalence of anemiaAntiretroviral therapyHuman immunodeficiency virus (HIV) infectionActive antiretroviral therapyCombination antiretroviral therapyImmunodeficiency virus infectionHIV-positive womenYears of treatmentIncrease of hemoglobinImproved anemiaMulticenter cohortVirus infectionHAARTAnemiaHIVWomenTherapyLinear regression modelsPrevalenceTreatmentBaselineHemoglobinRegression modelsSignificant changesMonotherapyInjecting misuse of buprenorphine among French drug users
Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J. Injecting misuse of buprenorphine among French drug users. Addiction 2001, 96: 267-272. PMID: 11182872, DOI: 10.1046/j.1360-0443.2001.96226710.x.Peer-Reviewed Original ResearchConceptsDrug maintenance treatmentSample of IDUsNeedle exchange programsDrug usersMisuse of buprenorphineCross-sectional surveySelf-administered questionnaireAmbulatory prescriptionsMaintenance treatmentAmbulatory careCommunity pharmaciesBuprenorphineSterile syringesSubstantial riskIDUsLatter groupIllicit usePolydrug usersHIVExchange programsMonthsRisky behaviorsPrescriptionPharmacyMisuseCharacteristics of injection drug using parents who retain their children
Pilowsky D, Lyles C, Cross S, Celentano D, Nelson K, Vlahov D. Characteristics of injection drug using parents who retain their children. Drug And Alcohol Dependence 2001, 61: 113-122. PMID: 11137275, DOI: 10.1016/s0376-8716(00)00130-7.Peer-Reviewed Original ResearchConceptsInjection drug usersClinical symptomsHIV-positive parentsActive drug useAge 14High-risk practicesHIV statusInjection drugsRetention of childrenDrug usersDrug useAsymptomatic parentsHealth factorsHIVDrug practicesHealth insuranceChildrenPositive parentsCommunity sampleSymptomsRelated behaviorsParentsIllness
2000
HIV testing and retesting for men and women in Switzerland
Zwahlen M, Neuenschwander B, Jeannin A, Dubois-Arber F, Vlahov D. HIV testing and retesting for men and women in Switzerland. European Journal Of Epidemiology 2000, 16: 123-133. PMID: 10845261, DOI: 10.1023/a:1007638823567.Peer-Reviewed Original Research
1999
Self-Reported Bacterial Infections Among Women with or at Risk for Human Immunodeficiency Virus Infection
Flanigan T, Hogan J, Smith D, Schoenbaum E, Vlahov D, Schuman P, Mayer K. Self-Reported Bacterial Infections Among Women with or at Risk for Human Immunodeficiency Virus Infection. Clinical Infectious Diseases 1999, 29: 608-612. PMID: 10530455, DOI: 10.1086/598641.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionCD4 cell countImmunodeficiency virus infectionBacterial infectionsRecent pneumoniaVirus infectionCell countHIV-negative womenHIV-seropositive womenUrinary tract infectionInjection drug useLogistic regression analysisSelf-reported pneumoniaCross-sectional analysisSeronegative womenTract infectionsHIV infectionDrug useLifetime historyInfectionPneumoniaMajor causeWomenRegression analysisCell categoriesSex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters
Sterling T, Lyles C, Vlahov D, Astemborski J, Margolick J, Quinn T. Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters. The Journal Of Infectious Diseases 1999, 180: 666-672. PMID: 10438353, DOI: 10.1086/314967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus type 1 RNA levelsHIV-1 seroconvertersSex differencesCopies/mLHIV-1 pathogenesisInjection drug usersCase-control studyTime of seroconversionCross-sectional studyCourse of infectionMale patientsRapid progressorsFemale patientsCopies/Drug usersMale controlsVirus levelsPatientsRNA levelsSeroconvertersWomenMenNonprogressorsSeroconversionProgressorsComparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral Load
Rompalo A, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg S, Warren D, Farzadegan H, Vlahov D, Smith D. Comparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral Load. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 448-454. PMID: 10225226, DOI: 10.1097/00042560-199904150-00006.Peer-Reviewed Original ResearchMeSH KeywordsAdultCD4 Lymphocyte CountCross-Sectional StudiesFemaleHeterosexualityHIV InfectionsHIV-1HumansMaleRisk FactorsSubstance Abuse, IntravenousViral LoadConceptsHIV-1 viral loadPlasma viral loadBody mass indexHIV-1 plasma viral loadOral hairy leukoplakiaInjection drug useViral loadInjection drug usersRisk groupsHIV infectionCell countDrug useHairy leukoplakiaCells/Clinical manifestationsHeterosexual contactMedian HIV-1 viral loadPlasma HIV-1 viral loadUndetectable HIV-1 viral loadPlasma viral load levelsHIV viral loadIntravenous drug useViral load levelsPopulation of HIVPrevalence of HIVHIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old
Carneiro M, Fuller C, Doherty M, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug And Alcohol Dependence 1999, 54: 83-86. PMID: 10101620, DOI: 10.1016/s0376-8716(98)00142-2.Peer-Reviewed Original ResearchConceptsInjection drug usersInjection drug useRisk behaviorsDrug usersDrug useCross-sectional studyRates of HIVHigh-risk behaviorsAge of initiationHIV infectionHIV prevalenceFirst injectionWide age rangeAverage ageNew initiatesHygiene practicesAge rangeAgeRecruitment techniquesInjectionYearsHIVInitiationInfectionPrevalenceCompliance With Universal Precautions in Correctional Health Care Facilities
Gershon R, Karkashian C, Vlahov D, Kummer L, Kasting C, Green-McKenzie J, Escamilla-Cejudo J, Kendig N, Swetz A, Martin L. Compliance With Universal Precautions in Correctional Health Care Facilities. Journal Of Occupational And Environmental Medicine 1999, 41: 181-189. PMID: 10091141, DOI: 10.1097/00043764-199903000-00007.Peer-Reviewed Original ResearchConceptsHealth care workersBloodborne exposuresUniversal precautionsCare workersCompliance rateCorrectional health care workersCorrectional health-care facilitiesBody fluid exposuresCross-sectional studyHealth care facilitiesPersonal protective equipmentCorrelates of complianceSharps disposalModifiable correlatesProtective eyewearInterventional strategiesFluid exposureCare facilitiesOverall complianceProtective equipmentCompliance ScaleFace maskAdverse working conditionsDemographic factorsExposure